Limiting antibiotic manufacturing discharge in Indian wastewater

  13 March 2020

The need for regulations to tackle the spread of antimicrobial resistance (AMR) has become increasingly apparent as almost 60,000 infants die annually due to superbug infections in India.1 Why is this happening and what can governments do to prevent it?

Most pharmaceutical companies strive to maintain high quality drug manufacturing processes, yet this is not always achieved across the board.

During the manufacture of antibiotics, residual material and ingredients can percolate into water, which is then discharged into the surrounding environment. This can contribute to the emergence and spread of AMR, presenting major problems for the pharmaceutical industry, particularly antibiotic manufacturers and global healthcare.

Author(s): European Pharmaceutical Review
Clean Environment  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!